Showing results (201-210 of 318) with videos related to
Sort By:
Pageof 32
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 9, 2019
Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium ExperienceBadi El Osta, Madhusmita Behera, Sungjin Kim, et al.American Journal of Clinical Pathology|August 15, 2025
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implicationsAli AlJabban, Roberta S Azevedo, Katherine Antel, et al.JCO Precision Oncology|September 14, 2020
Engaging Patients in Precision Oncology: Development and Usability of a Web-Based Patient-Facing Genomic Sequencing ReportIlana B Solomon, Sarah McGraw, Jenny Shen, et al.American Journal of Respiratory and Critical Care Medicine|September 22, 2021
A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary VasculaturePaul B Dieffenbach, Christina Mallarino Haeger, Rakhshinda Rehman, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 7, 2016
Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomasLauren L Ritterhouse, Jonathan A Nowak, Kyle C Strickland, et al.Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.Archives of Pathology & Laboratory Medicine|April 16, 2024
Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity FoundationLynette M Sholl, Mark Awad, Upal Basu Roy, et al.Biorxiv : the Preprint Server for Biology|June 3, 2024
Leukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts in lung fibrosisHung N Nguyen, Yunju Jeong, Yunhye Kim, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.Frontiers in Oncology|February 12, 2024
Development and evaluation of INT<sup>2</sup>GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndromeRaymond A Isidro, Anu Chittenden, McKenzie Walker, et al.Pageof 32